Nuclear medicine sector argues for dedicated scheme to unlock cancer therapies

February 4, 2026 Latest News BioPharma

This is a preview of subscriber content

Subscribe now to continue reading.

Australia’s nuclear medicine sector is urging the Commonwealth to establish a dedicated national funding stream for radiopharmaceutical cancer therapies …

Subscribe now to continue reading.

Latest Video

Georgia Forrest

Sandoz adds to vision care options with the listing of biosimilar
February 2, 2026 - Latest News
If you're going to pay for reforms, are these the changes you want to pay for?
February 3, 2026 - Latest News
PYC’s capital raise marks one of the largest biotech fundraisings in Australian market history
February 2, 2026 - Australian Biotech
AusBiotech urges adoption of national life sciences strategy as global competition intensifies
February 2, 2026 - Australian Biotech
Medicines Australia calls for Budget action to restore access to innovative medicines
February 3, 2026 - Latest News

Nuclear medicine sector argues for dedicated scheme to unlock cancer therapies

This is a preview of subscriber content

Latest Video

Most Read

Sandoz adds to vision care options with the listing of biosimilar

If you're going to pay for reforms, are these the changes you want to pay for?

PYC’s capital raise marks one of the largest biotech fundraisings in Australian market history

AusBiotech urges adoption of national life sciences strategy as global competition intensifies

Medicines Australia calls for Budget action to restore access to innovative medicines

New Stories

GBMA moves to reclaim the reform agenda with a focus on pricing and supply

Nuclear medicine sector argues for dedicated scheme to unlock cancer therapies

Pfizer’s once-monthly weight-loss injection delivers strong mid-stage results

GBMA Summit focuses on access, affordability and security in an uncertain world

Medicines Australia calls for Budget action to restore access to innovative medicines

Survey exposes deep gaps in support for Australians living with rare cancers

Juvenile Arthritis Foundation Australia seeks new CEO as Angela McKay steps down

Sign In

Nuclear medicine sector argues for dedicated scheme to unlock cancer therapies

This is a preview of subscriber content

Latest Video

Most Read

Sandoz adds to vision care options with the listing of biosimilar

If you're going to pay for reforms, are these the changes you want to pay for?

PYC’s capital raise marks one of the largest biotech fundraisings in Australian market history

AusBiotech urges adoption of national life sciences strategy as global competition intensifies

Medicines Australia calls for Budget action to restore access to innovative medicines

Follow Us

New Stories

GBMA moves to reclaim the reform agenda with a focus on pricing and supply

Nuclear medicine sector argues for dedicated scheme to unlock cancer therapies

Pfizer’s once-monthly weight-loss injection delivers strong mid-stage results

GBMA Summit focuses on access, affordability and security in an uncertain world

Medicines Australia calls for Budget action to restore access to innovative medicines

Survey exposes deep gaps in support for Australians living with rare cancers

Juvenile Arthritis Foundation Australia seeks new CEO as Angela McKay steps down